AmerisourceBergen Pleads Guilty, Pays $260M For Repackaging Cancer Drugs
BROOKLYN, N.Y. — AmerisourceBergen Specialty Group on Sept. 27 pleaded guilty to illegally distributing adulterated cancer drugs and agreed to pay $260 million in criminal fines and criminal forfeiture (United States...To view the full article, register now.
Already a subscriber? Click here to view full article